Cite

HARVARD Citation

    Mallory, R. et al. (2017). A phase 1 study to evaluate the safety and pharmacokinetics of MEDI8852, an anti-influenza A monoclonal antibody, in healthy adult volunteers. Biologicals. pp. 81-86. [Online]. 
  
Back to record